Auto Added by WPeMatico
These bills cover everything from allowances for social equity applicants to decriminalizing hallucinogenic substances, and their fate will be decided by Oct. 14.
The post California Gov. Gavin Newsom To Review 17 Cannabis, Psychedelics Bills appeared first on High Times.
Ketamine therapy is now being offered across the country as an addition to existing employee health plans in a first-of-its-kind move by a national provider of insurance for psychedelic-assisted therapy.
The post Ketamine Therapy Offered as Employee Health Benefit Nationwide appeared first on High Times.
Enveric Biosciences (NASDAQ: ENVB) announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,752,130, titled “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s EVM301 Series of molecules being developed as potential treatments for mental health disorders. “Our EVM301 Series consists of small molecule therapies designed with the intent […]
The post Enveric Receives Patent For Psilocybin Molecules appeared first on Green Market Report.
Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced top-line data demonstrating clinically meaningful treatment effects across multiple endpoints and a well-tolerated safety profile from the double-blind, placebo-controlled cohort (Part 2) of its Phase II study of SLS-002 (intranasal racemic ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in adults with Major Depressive Disorder (MDD). However, while Montgomery-Åsberg […]
The post Seelos Reports Mixed Results From Phase II Ketamine Study appeared first on Green Market Report.
From politicians to patients, many people spoke at a recent public hearing that will influence a panel’s decision to study ibogaine as a treatment for opioid use disorder.
The post Kentucky Public Hearing Spotlights Testimonies of Ibogaine Patients appeared first on High Times.
Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), closed its United States-only public offering raising approximately $2.25 million. The offering consisted of 7,500,000 common shares and pre-funded warrants and 7,500,000 common warrants. Clearmind said it plans to use the money for general corporate purposes, which may include operating expenses, research, and development, including clinical and pre-clinical […]
The post Clearmind Medicine Raises $2.25 Million appeared first on Green Market Report.
Three months of legal psilocybin service with EPIC Healing Eugene show that thousands of people are reaching out to participate.
The post Oregon Psilocybin Service Centers Set High Prices, Thousands Have Already Waitlisted appeared first on High Times.
